We then performed mIHC staining in these tumor sections to analyze the co-localization of PD-1, CD38 and CD8, and further compare the expression of CD38 and PD-1 on CD8+ cells across different patient groups (Figure 7B). The gene discussed is CD8A; the disease is neoplasm.